Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$7.06 - $13.97 $87,374 - $172,892
-12,376 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$12.15 - $35.28 $2.6 Million - $7.56 Million
-214,328 Reduced 94.54%
12,376 $150,000
Q4 2021

Feb 14, 2022

SELL
$30.49 - $48.49 $323,773 - $514,915
-10,619 Reduced 4.47%
226,704 $7.74 Million
Q3 2021

Nov 15, 2021

BUY
$41.66 - $52.52 $30,495 - $38,444
732 Added 0.31%
237,323 $11.4 Million
Q2 2021

Aug 13, 2021

BUY
$36.62 - $51.69 $63,096 - $89,061
1,723 Added 0.73%
236,591 $10.7 Million
Q1 2021

May 17, 2021

SELL
$41.56 - $59.88 $1.59 Million - $2.29 Million
-38,232 Reduced 14.0%
234,868 $11.3 Million
Q4 2020

Feb 16, 2021

SELL
$36.08 - $56.47 $62,598 - $97,975
-1,735 Reduced 0.63%
273,100 $14.7 Million
Q3 2020

Nov 16, 2020

BUY
$33.26 - $40.48 $187,253 - $227,902
5,630 Added 2.09%
274,835 $10.1 Million
Q2 2020

Aug 13, 2020

BUY
$24.21 - $31.02 $5.57 Million - $7.13 Million
229,966 Added 586.06%
269,205 $8.34 Million
Q1 2020

May 15, 2020

SELL
$20.5 - $34.53 $191,285 - $322,199
-9,331 Reduced 19.21%
39,239 $1.08 Million
Q3 2019

Nov 14, 2019

SELL
$19.12 - $26.24 $382 - $524
-20 Reduced 0.04%
48,570 $929,000
Q2 2019

Aug 12, 2019

SELL
$19.57 - $24.1 $33,953 - $41,813
-1,735 Reduced 3.45%
48,590 $1.07 Million
Q1 2019

May 14, 2019

BUY
$12.14 - $20.46 $134,450 - $226,594
11,075 Added 28.22%
50,325 $1.03 Million
Q4 2018

Feb 08, 2019

BUY
$11.24 - $18.5 $441,170 - $726,125
39,250 New
39,250 $495,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track American Capital Management Inc Portfolio

Follow American Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Management Inc with notifications on news.